Cargando…

Targeted Proteomic Quantitation of the Absolute Expression and Turnover of Cystic Fibrosis Transmembrane Conductance Regulator in the Apical Plasma Membrane

[Image: see text] Deficient chloride transport through cystic fibrosis (CF) transmembrane conductance regulator (CFTR) causes lethal complications in CF patients. CF is the most common autosomal recessive genetic disease, which is caused by mutations in the CFTR gene; thus, CFTR mutants can serve as...

Descripción completa

Detalles Bibliográficos
Autores principales: McShane, Adam J., Bajrami, Bekim, Ramos, Alex A., Diego-Limpin, Pamela A., Farrokhi, Vahid, Coutermarsh, Bonita A., Stanton, Bruce A., Jensen, Tim, Riordan, John R., Wetmore, Diana, Joseloff, Elizabeth, Yao, Xudong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227562/
https://www.ncbi.nlm.nih.gov/pubmed/25227318
http://dx.doi.org/10.1021/pr5006795
_version_ 1782343830263037952
author McShane, Adam J.
Bajrami, Bekim
Ramos, Alex A.
Diego-Limpin, Pamela A.
Farrokhi, Vahid
Coutermarsh, Bonita A.
Stanton, Bruce A.
Jensen, Tim
Riordan, John R.
Wetmore, Diana
Joseloff, Elizabeth
Yao, Xudong
author_facet McShane, Adam J.
Bajrami, Bekim
Ramos, Alex A.
Diego-Limpin, Pamela A.
Farrokhi, Vahid
Coutermarsh, Bonita A.
Stanton, Bruce A.
Jensen, Tim
Riordan, John R.
Wetmore, Diana
Joseloff, Elizabeth
Yao, Xudong
author_sort McShane, Adam J.
collection PubMed
description [Image: see text] Deficient chloride transport through cystic fibrosis (CF) transmembrane conductance regulator (CFTR) causes lethal complications in CF patients. CF is the most common autosomal recessive genetic disease, which is caused by mutations in the CFTR gene; thus, CFTR mutants can serve as primary targets for drugs to modulate and rescue the ion channel’s function. The first step of drug modulation is to increase the expression of CFTR in the apical plasma membrane (PM); thus, accurate measurement of CFTR in the PM is desired. This work reports a tandem enrichment strategy to prepare PM CFTR and uses a stable isotope labeled CFTR sample as the quantitation reference to measure the absolute amount of apical PM expression of CFTR in CFBE 41o- cells. It was found that CFBE 41o- cells expressing wild-type CFTR (wtCFTR), when cultured on plates, had 2.9 ng of the protein in the apical PM per million cells; this represented 10% of the total CFTR found in the cells. When these cells were polarized on filters, the apical PM expression of CFTR increased to 14%. Turnover of CFTR in the apical PM of baby hamster kidney cells overexpressing wtCFTR (BHK-wtCFTR) was also quantified by targeted proteomics based on multiple reaction monitoring mass spectrometry; wtCFTR had a half-life of 29.0 ± 2.5 h in the apical PM. This represents the first direct measurement of CFTR turnover using stable isotopes. The absolute quantitation and turnover measurements of CFTR in the apical PM can significantly facilitate understanding the disease mechanism of CF and thus the development of new disease-modifying drugs. Absolute CFTR quantitation allows for direct result comparisons among analyses, analysts, and laboratories and will greatly amplify the overall outcome of CF research and therapy.
format Online
Article
Text
id pubmed-4227562
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-42275622015-09-16 Targeted Proteomic Quantitation of the Absolute Expression and Turnover of Cystic Fibrosis Transmembrane Conductance Regulator in the Apical Plasma Membrane McShane, Adam J. Bajrami, Bekim Ramos, Alex A. Diego-Limpin, Pamela A. Farrokhi, Vahid Coutermarsh, Bonita A. Stanton, Bruce A. Jensen, Tim Riordan, John R. Wetmore, Diana Joseloff, Elizabeth Yao, Xudong J Proteome Res [Image: see text] Deficient chloride transport through cystic fibrosis (CF) transmembrane conductance regulator (CFTR) causes lethal complications in CF patients. CF is the most common autosomal recessive genetic disease, which is caused by mutations in the CFTR gene; thus, CFTR mutants can serve as primary targets for drugs to modulate and rescue the ion channel’s function. The first step of drug modulation is to increase the expression of CFTR in the apical plasma membrane (PM); thus, accurate measurement of CFTR in the PM is desired. This work reports a tandem enrichment strategy to prepare PM CFTR and uses a stable isotope labeled CFTR sample as the quantitation reference to measure the absolute amount of apical PM expression of CFTR in CFBE 41o- cells. It was found that CFBE 41o- cells expressing wild-type CFTR (wtCFTR), when cultured on plates, had 2.9 ng of the protein in the apical PM per million cells; this represented 10% of the total CFTR found in the cells. When these cells were polarized on filters, the apical PM expression of CFTR increased to 14%. Turnover of CFTR in the apical PM of baby hamster kidney cells overexpressing wtCFTR (BHK-wtCFTR) was also quantified by targeted proteomics based on multiple reaction monitoring mass spectrometry; wtCFTR had a half-life of 29.0 ± 2.5 h in the apical PM. This represents the first direct measurement of CFTR turnover using stable isotopes. The absolute quantitation and turnover measurements of CFTR in the apical PM can significantly facilitate understanding the disease mechanism of CF and thus the development of new disease-modifying drugs. Absolute CFTR quantitation allows for direct result comparisons among analyses, analysts, and laboratories and will greatly amplify the overall outcome of CF research and therapy. American Chemical Society 2014-09-16 2014-11-07 /pmc/articles/PMC4227562/ /pubmed/25227318 http://dx.doi.org/10.1021/pr5006795 Text en Copyright © 2014 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle McShane, Adam J.
Bajrami, Bekim
Ramos, Alex A.
Diego-Limpin, Pamela A.
Farrokhi, Vahid
Coutermarsh, Bonita A.
Stanton, Bruce A.
Jensen, Tim
Riordan, John R.
Wetmore, Diana
Joseloff, Elizabeth
Yao, Xudong
Targeted Proteomic Quantitation of the Absolute Expression and Turnover of Cystic Fibrosis Transmembrane Conductance Regulator in the Apical Plasma Membrane
title Targeted Proteomic Quantitation of the Absolute Expression and Turnover of Cystic Fibrosis Transmembrane Conductance Regulator in the Apical Plasma Membrane
title_full Targeted Proteomic Quantitation of the Absolute Expression and Turnover of Cystic Fibrosis Transmembrane Conductance Regulator in the Apical Plasma Membrane
title_fullStr Targeted Proteomic Quantitation of the Absolute Expression and Turnover of Cystic Fibrosis Transmembrane Conductance Regulator in the Apical Plasma Membrane
title_full_unstemmed Targeted Proteomic Quantitation of the Absolute Expression and Turnover of Cystic Fibrosis Transmembrane Conductance Regulator in the Apical Plasma Membrane
title_short Targeted Proteomic Quantitation of the Absolute Expression and Turnover of Cystic Fibrosis Transmembrane Conductance Regulator in the Apical Plasma Membrane
title_sort targeted proteomic quantitation of the absolute expression and turnover of cystic fibrosis transmembrane conductance regulator in the apical plasma membrane
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227562/
https://www.ncbi.nlm.nih.gov/pubmed/25227318
http://dx.doi.org/10.1021/pr5006795
work_keys_str_mv AT mcshaneadamj targetedproteomicquantitationoftheabsoluteexpressionandturnoverofcysticfibrosistransmembraneconductanceregulatorintheapicalplasmamembrane
AT bajramibekim targetedproteomicquantitationoftheabsoluteexpressionandturnoverofcysticfibrosistransmembraneconductanceregulatorintheapicalplasmamembrane
AT ramosalexa targetedproteomicquantitationoftheabsoluteexpressionandturnoverofcysticfibrosistransmembraneconductanceregulatorintheapicalplasmamembrane
AT diegolimpinpamelaa targetedproteomicquantitationoftheabsoluteexpressionandturnoverofcysticfibrosistransmembraneconductanceregulatorintheapicalplasmamembrane
AT farrokhivahid targetedproteomicquantitationoftheabsoluteexpressionandturnoverofcysticfibrosistransmembraneconductanceregulatorintheapicalplasmamembrane
AT coutermarshbonitaa targetedproteomicquantitationoftheabsoluteexpressionandturnoverofcysticfibrosistransmembraneconductanceregulatorintheapicalplasmamembrane
AT stantonbrucea targetedproteomicquantitationoftheabsoluteexpressionandturnoverofcysticfibrosistransmembraneconductanceregulatorintheapicalplasmamembrane
AT jensentim targetedproteomicquantitationoftheabsoluteexpressionandturnoverofcysticfibrosistransmembraneconductanceregulatorintheapicalplasmamembrane
AT riordanjohnr targetedproteomicquantitationoftheabsoluteexpressionandturnoverofcysticfibrosistransmembraneconductanceregulatorintheapicalplasmamembrane
AT wetmorediana targetedproteomicquantitationoftheabsoluteexpressionandturnoverofcysticfibrosistransmembraneconductanceregulatorintheapicalplasmamembrane
AT joseloffelizabeth targetedproteomicquantitationoftheabsoluteexpressionandturnoverofcysticfibrosistransmembraneconductanceregulatorintheapicalplasmamembrane
AT yaoxudong targetedproteomicquantitationoftheabsoluteexpressionandturnoverofcysticfibrosistransmembraneconductanceregulatorintheapicalplasmamembrane